Evidence map›Paper›PMID 10933074›Full record

ReviewNeoplasia (New York, N.Y.)

Applications of magnetic resonance in model systems: cancer therapeutics.

J L Evelhoch, R J Gillies, G S Karczmar, J A Koutcher, R J Maxwell, O Nalcioglu, N Raghunand, S M Ronen, B D Ross, H M Swartz

Open access · goldAbstract readReview
In one paragraph

Review in Neoplasia (New York, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 133 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.IEEE journal of selected topics in quantum electronics : a publication of the IEEE Lasers and Electro-optics Society · 2012
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

J L EvelhochBarbara Ann Karmanos Cancer Institute and Department of Internal Medicine, Wayne State University, Detroit, MI, USA. evelhoch@med.wayne.edu
R J Gillies
G S Karczmar
J A Koutcher
R J Maxwell
O Nalcioglu
N Raghunand
S M Ronen
B D Ross
H M Swartz
Arizona Oncology · USDartmouth College · USImaging Center · USMemorial Sloan Kettering Cancer Center · USRoyal Marsden Hospital · GBThe Barbara Ann Karmanos Cancer Institute · USUniversity of Chicago · USUniversity of Michigan–Ann Arbor · US

Funding

Causes & Consequences of Acid pH in TumorsR01CA077575 · NCI · UNIVERSITY OF ARIZONA · PI GILLIES, ROBERT J. · 1999 to 2018
$8.5M
USE OF SOLUBLE TRITYL SPIN PROBES FOR EPR OXIMETRY INVESTIGATIONSP41RR011602 · NCRR · DARTMOUTH COLLEGE · PI SWARTZ, HAROLD M · 1996 to 2002
$1.7M
EFFECTS OF RADIOSENSITIZERS MEASURED BY MRIR01CA075476 · NCI · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S · 1999 to 2001
$325k
NMR SPECTROSCOPY: TUMOR RADIATION RESPONSE PREDICTORR01CA043113 · NCI · WAYNE STATE UNIVERSITY · PI EVELHOCH, JEFFREY L · 1986 to 1994
–
NCI NIH HHS CA43113NCI NIH HHS CA75476NCI NIH HHS CA83041NCI NIH HHS R01 CA077575NCRR NIH HHS P41 RR011602
6 · The paper itself

Abstract

The lack of information regarding the metabolism and pathophysiology of individual tumors limits, in part, both the development of new anti-cancer therapies and the optimal implementation of currently available treatments. Magnetic resonance [MR, including magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and electron paramagnetic resonance (EPR)] provides a powerful tool to assess many aspects of tumor metabolism and pathophysiology. Moreover, since this information can be obtained nondestructively, pre-clinical results from cellular or animal models are often easily translated into the clinic. This review presents selected examples of how MR has been used to identify metabolic changes associated with apoptosis, detect therapeutic response prior to a change in tumor volume, optimize the combination of metabolic inhibitors with chemotherapy and/or radiation, characterize and exploit the influence of tumor pH on the effectiveness of chemotherapy, characterize tumor reoxygenation and the effects of modifiers of tumor oxygenation in individual tumors, image transgene expression and assess the efficacy of gene therapy. These examples provide an overview of several of the areas in which cellular and animal model studies using MR have contributed to our understanding of the effects of treatment on tumor metabolism and pathophysiology and the importance of tumor metabolism and pathophysiology as determinants of therapeutic response.

Indexed as

AnimalsApoptosisHumansMagnetic Resonance ImagingNeoplasmsTime Factors

Identifiers

PMID10933074
PMCPMC1531871
OpenAlexW2079442902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.